Evaluation of four different small animal radiation plans on tumour and normal tissue dosimetry in a glioblastoma mouse model.
Animals
Brain
/ pathology
Disease Models, Animal
Female
Glioblastoma
/ radiotherapy
Magnetic Resonance Imaging
/ methods
Mice
Organs at Risk
/ radiation effects
Radiometry
/ methods
Radiotherapy Dosage
/ veterinary
Radiotherapy Planning, Computer-Assisted
/ methods
Radiotherapy, Conformal
/ methods
Tomography, X-Ray Computed
/ methods
Journal
The British journal of radiology
ISSN: 1748-880X
Titre abrégé: Br J Radiol
Pays: England
ID NLM: 0373125
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
pubmed:
27
10
2018
medline:
5
3
2019
entrez:
27
10
2018
Statut:
ppublish
Résumé
Small animal radiotherapy research platforms such as XStrahl's SARRP enable more precise irradiation of tumours and normal tissues in pre-clinical models of cancer. Using an orthotopic G7 glioblastoma xenograft model we studied the impact of four different radiotherapy plans on tumour and normal tissue dosimetry. Plans were created using four different approaches (single beam, parallel opposed pair, single plane arcs, couch rotation arcs) and dose volume histograms (DVH) for the tumour and the relevant organs at risk (OARs) (mouth, ipsilateral brain, contralateral brain, brain stem) were compared for a sample mouse subject. To evaluate the accuracy of delivery, treatment plans were recreated in solid-water phantoms and delivered to radiochromic film. Favourable tumour dosimetry was achieved by all plans. DVH analysis showed that different plans could be used to spare specific OARs depending on the objectives of the study. The delivery accuracy of the various treatments was better than 2%/2mm (dose difference/distance to agreement) in terms of global γ analysis. Small animal radiotherapy research platforms are an exciting addition to the pre-clinical research environment. Such systems improve the conformality of irradiation of tumours and OARs while maintaining a high degree of accuracy and enable investigators to optimise experiments in terms of tumour coverage and inclusion or exclusion of relevant OARs. This study confirms the utility of the SARRP in terms of the accuracy of plan delivery, and informs decisions on treatment planning to optimise the clinical relevance and scientific value of experiments.
Identifiants
pubmed: 30362815
doi: 10.1259/bjr.20180469
pmc: PMC6541187
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
20180469Références
Med Phys. 2001 Jun;28(6):868-93
pubmed: 11439485
Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1591-9
pubmed: 18640502
Phys Med Biol. 2011 Jun 21;56(12):R55-83
pubmed: 21617291
Phys Med. 2013 Nov;29(6):599-606
pubmed: 23107430
Cancer Res. 2015 Oct 15;75(20):4416-28
pubmed: 26282173
Neuro Oncol. 2017 Feb 1;19(2):229-241
pubmed: 27576873
Radiother Oncol. 2018 Mar;126(3):471-478
pubmed: 29269093
Med Phys. 1998 May;25(5):656-61
pubmed: 9608475